HCM vs. BRK-B

Last updated Apr 2, 2026

Compare and contrast key facts about HUTCHMED (China) Limited (HCM) and Berkshire Hathaway Inc. (BRK-B).

Performance

HCM vs. BRK-B - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in HUTCHMED (China) Limited (HCM) and Berkshire Hathaway Inc. (BRK-B). The values are adjusted to include any dividend payments, if applicable.

HCM vs. BRK-B - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
HCM HUTCHMED (China) Limited	13.58%	-7.49%	-20.43%	22.53%	-57.87%	9.56%	27.72%	8.58%	-41.43%	190.49%
BRK-B Berkshire Hathaway Inc.	-4.80%	10.89%	27.09%	15.46%	3.31%	28.95%	2.37%	10.93%	3.01%	21.62%

Fundamentals

EPS HCM : $2.68 BRK-B : $31.03
PE Ratio HCM : 5.66 BRK-B : 15.42
PEG Ratio HCM : 0.01 BRK-B : 0.60
PS Ratio HCM : 4.39 BRK-B : 2.78
Total Revenue (TTM) HCM : $602.20M BRK-B : $371.37B
Gross Profit (TTM) HCM : $53.76M BRK-B : $116.89B
EBITDA (TTM) HCM : -$7.49M BRK-B : $87.30B

Returns By Period

In the year-to-date period, HCM achieves a 13.58% return, which is significantly higher than BRK-B's -4.80% return. Over the past 10 years, HCM has underperformed BRK-B with an annualized return of 1.15%, while BRK-B has yielded a comparatively higher 12.78% annualized return.

HCM

• 1D: 1.20%
• 1M: 8.96%
• YTD: 13.58%
• 6M: -5.14%
• 1Y: -5.73%
• 3Y*: 5.16%
• 5Y*: -11.25%
• 10Y*: 1.15%

BRK-B

• 1D: -0.15%
• 1M: -0.35%
• YTD: -4.80%
• 6M: -3.95%
• 1Y: -10.22%
• 3Y*: 15.72%
• 5Y*: 13.13%
• 10Y*: 12.78%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

HCM vs. BRK-B — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HCM

HCM Risk / Return Rank: 36
HCM Sharpe Ratio Rank: 34
HCM Sortino Ratio Rank: 32
HCM Omega Ratio Rank: 32
HCM Calmar Ratio Rank: 40
HCM Martin Ratio Rank: 40

BRK-B

BRK-B Risk / Return Rank: 17
BRK-B Sharpe Ratio Rank: 16
BRK-B Sortino Ratio Rank: 16
BRK-B Omega Ratio Rank: 16
BRK-B Calmar Ratio Rank: 17
BRK-B Martin Ratio Rank: 19

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HCM vs. BRK-B - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for HUTCHMED (China) Limited (HCM) and Berkshire Hathaway Inc. (BRK-B). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	HCM	BRK-B	Difference
Sharpe ratio Return per unit of total volatility	-0.12	-0.56	+0.44
Sortino ratio Return per unit of downside risk	0.16	-0.65	+0.81
Omega ratio Gain probability vs. loss probability	1.02	0.91	+0.11
Calmar ratio Return relative to maximum drawdown	0.02	-0.68	+0.70
Martin ratio Return relative to average drawdown	0.03	-1.16	+1.20
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

HCM vs. BRK-B - Sharpe Ratio Comparison

The current HCM Sharpe Ratio is -0.12, which is higher than the BRK-B Sharpe Ratio of -0.56. The chart below compares the historical Sharpe Ratios of HCM and BRK-B, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	HCM	BRK-B	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.12	-0.56	+0.44
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.17	0.77	-0.94
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.02	0.66	-0.64
Sharpe Ratio (All Time) Calculated using the full available price history	0.02	0.48	-0.46

Correlation

The correlation between HCM and BRK-B is 0.15, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

HCM vs. BRK-B - Dividend Comparison

Neither HCM nor BRK-B has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

HCM vs. BRK-B - Drawdown Comparison

The maximum HCM drawdown since its inception was -82.18%, which is greater than BRK-B's maximum drawdown of -53.86%. Use the drawdown chart below to compare losses from any high point for HCM and BRK-B.

Drawdown Indicators

	HCM	BRK-B	Difference
Max Drawdown Largest peak-to-trough decline	-82.18%	-53.86%	-28.32%
Max Drawdown (1Y) Largest decline over 1 year	-31.39%	-14.95%	-16.44%
Max Drawdown (5Y) Largest decline over 5 years	-82.18%	-26.58%	-55.60%
Max Drawdown (10Y) Largest decline over 10 years	-82.18%	-29.57%	-52.61%
Current Drawdown Current decline from peak	-64.74%	-11.36%	-53.38%
Average Drawdown Average peak-to-trough decline	-39.67%	-11.07%	-28.60%
Ulcer Index Depth and duration of drawdowns from previous peaks	19.55%	8.72%	+10.83%

Volatility

HCM vs. BRK-B - Volatility Comparison

HUTCHMED (China) Limited (HCM) has a higher volatility of 9.32% compared to Berkshire Hathaway Inc. (BRK-B) at 4.33%. This indicates that HCM's price experiences larger fluctuations and is considered to be riskier than BRK-B based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	HCM	BRK-B	Difference
Volatility (1M) Calculated over the trailing 1-month period	9.32%	4.33%	+4.99%
Volatility (6M) Calculated over the trailing 6-month period	21.70%	11.14%	+10.56%
Volatility (1Y) Calculated over the trailing 1-year period	47.83%	18.30%	+29.53%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	66.28%	17.20%	+49.08%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	59.46%	19.45%	+40.01%

Financials